Mersana Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Mersana Therapeutics will hold its annual stockholder meeting on June 12, 2025, to vote on director elections, executive compensation, auditor ratification, and a proposed reverse stock split.
DEF: Mersana Therapeutics Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Mersana Therapeutics is asking stockholders to approve a reverse stock split to boost its stock price and maintain its Nasdaq listing.
Mersana Therapeutics announces its annual stockholder meeting to be held virtually on June 11, 2024, with voting open until June 10, 2024.
Mersana Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 11, 2024, covering director elections, executive compensation, and auditor ratification.